ENTITY
BB Biotech AG

BB Biotech AG (BION SW)

13
Analysis
Health Care • Switzerland
BB Biotech AG is a closed-ended investment trust. It invests in biotech companies that operate in areas that include oncology, cardiovascular diseases, infectious diseases and autoimmune diseases.
more
bullish•BB Biotech AG
•25 Oct 2023 19:10•Issuer-paid

BB Biotech - A cutting-edge sector and a high dividend

BB Biotech (BION) offers investors exposure to the innovative, rapidly expanding biotech sector. BION is the largest biotech investor among its...

Share
bullish•BB Biotech AG
•03 Mar 2023 20:05•Issuer-paid

BB Biotech - Picking growth at good value

According to BB Biotech’s (BION’s) investment team, the biotech industry remains in a very good position. Following a sell-off in the last two...

Share
bullish•BB Biotech AG
•13 Sep 2022 22:56•Issuer-paid

BB Biotech - Great valuation potential

According to BB Biotech’s (BION) investment team, the biotech industry has never looked in such a good position. Following a sell-off in the last...

Share
bullish•BB Biotech AG
•15 Dec 2020 20:08•Issuer-paid

Video: BB Biotech - fund manager interview

Daniel Koller, lead fund manager of Switzerland-based BB Biotech, reflects on an extraordinary year for the world at large and the healthcare...

Share
bullish•BB Biotech AG
•16 Apr 2020 19:02•Issuer-paid

BB Biotech - RNA focus provides a possible COVID-19 solution

BB Biotech (BION) recently updated the market on its views on the COVID-19 pandemic and how they are reflected in its portfolio (see video link...

Share
x